These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35063646)

  • 21. The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-Raf and MAPK signaling cascade.
    Qian Y; Zhou L; Luk STY; Xu J; Li W; Gou H; Chen H; Kang W; Yu J; Wong CC
    Oncogene; 2023 Feb; 42(8):601-612. PubMed ID: 36564468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
    Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
    Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.
    van Houdt WJ; de Bruijn MT; Emmink BL; Raats D; Hoogwater FJ; Borel Rinkes IH; Kranenburg O
    Cell Oncol; 2010 Jan; 32(4):245-57. PubMed ID: 20413844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression.
    Yang L; Ma DW; Cao YP; Li DZ; Zhou X; Feng JF; Bao J
    Theranostics; 2021; 11(8):3742-3759. PubMed ID: 33664859
    [No Abstract]   [Full Text] [Related]  

  • 25. Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.
    Zhang X; Li N; Li X; Zhao W; Qiao Y; Liang L; Ding Y
    J Gastroenterol Hepatol; 2012 Jun; 27(6):1117-25. PubMed ID: 22168621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of DAB2IP promotes mesenchymal-to-neuroepithelial transition and neuronal differentiation of human mesenchymal stem cells.
    Chang SL; Chou RH; Zeng HJ; Lin YH; Chiu TY; Yang DM; Hung SC; Lai CH; Hsieh JT; Shyu WC; Yu YL
    PLoS One; 2013; 8(9):e75884. PubMed ID: 24073285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation.
    Davis TB; Yang M; Schell MJ; Wang H; Ma L; Pledger WJ; Yeatman TJ
    Sci Rep; 2018 Jun; 8(1):9296. PubMed ID: 29915291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic Interactions between Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and Retinoic Acid Receptor Signaling in Colorectal Cancer Cells.
    Imajo M; Kondoh K; Yamamoto T; Nakayama K; Nakajima-Koyama M; Nishida E
    Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28483913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sophocarpine Inhibits Tumorgenesis of Colorectal Cancer via Downregulation of MEK/ERK/VEGF Pathway.
    Wang Q; Wang T; Zhu L; He N; Duan C; Deng W; Zhang H; Zhang X
    Biol Pharm Bull; 2019 Nov; 42(11):1830-1838. PubMed ID: 31434836
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Wang K; Gong D; Qiao X; Zheng J
    Life Sci Alliance; 2023 Apr; 6(5):. PubMed ID: 37085288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
    Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nobiletin induces inhibitions of Ras activity and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling to suppress cell proliferation in C6 rat glioma cells.
    Aoki K; Yokosuka A; Mimaki Y; Fukunaga K; Yamakuni T
    Biol Pharm Bull; 2013; 36(4):540-7. PubMed ID: 23546290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative regulation of DAB2IP by Akt and SCFFbw7 pathways.
    Dai X; North BJ; Inuzuka H
    Oncotarget; 2014 May; 5(10):3307-15. PubMed ID: 24912918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-allergic drug azelastine suppresses colon tumorigenesis by directly targeting ARF1 to inhibit IQGAP1-ERK-Drp1-mediated mitochondrial fission.
    Hu HF; Xu WW; Li YJ; He Y; Zhang WX; Liao L; Zhang QH; Han L; Yin XF; Zhao XX; Pan YL; Li B; He QY
    Theranostics; 2021; 11(4):1828-1844. PubMed ID: 33408784
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Leoni C; Montagner S; Rinaldi A; Bertoni F; Polletti S; Balestrieri C; Monticelli S
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):E1490-E1499. PubMed ID: 28167789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Block one, unleash a hundred. Mechanisms of DAB2IP inactivation in cancer.
    Bellazzo A; Di Minin G; Collavin L
    Cell Death Differ; 2017 Jan; 24(1):15-25. PubMed ID: 27858941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection.
    Zhang Q; Wei L; Yang H; Yang W; Yang Q; Zhang Z; Wu K; Wu J
    Cancer Lett; 2016 Feb; 371(1):107-16. PubMed ID: 26620707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smurf1 regulation of DAB2IP controls cell proliferation and migration.
    Li X; Dai X; Wan L; Inuzuka H; Sun L; North BJ
    Oncotarget; 2016 May; 7(18):26057-69. PubMed ID: 27036023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
    Lu HB
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6816-6823. PubMed ID: 30402845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.